Cited by 46Protein Kinase Regulation and GTPase SignalingAlzheimer's disease research and treatmentsNeuroscience and Neuropharmacology Research

Rho GTPases in neurodegeneration diseases

DeGeer, Jonathan, Lamarche-Vane, Nathalie·2013·Experimental Cell Research

Abstract

Rho GTPases are molecular switches that modulate multiple intracellular signaling processes by means of various effector proteins. As a result, Rho GTPase activities are tightly spatiotemporally regulated in order to ensure homeostasis within the cell. Though the roles of Rho GTPases during neural development have been well documented, their participation during neurodegeneration has been far less characterized. Herein we discuss our current knowledge of the role and function of Rho GTPases and regulators during neurodegeneration, and highlight their potential as targets for therapeutic intervention in common neurodegenerative disorders.

Integrity signals

Registry

Crossref · 10.1016/j.yexcr.2013.06.016

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In mammals, the RHO family consists of 20 members distributed into eight subfamilies based on sequence homology.

    “In mammals, the RHO family consists of 20 members in total, further distributed into eight subfamilies based on sequence homology: CDC42, RAC, RHO, RHOBTB, RHOD/F, RHOH, RHOU/V, and RND (9).”
  • Dysregulation of Rho GTPases has been studied in relation to cancer progression, but accumulating evidence supports a role in traumatic brain injury and neurodegenerative diseases.

    “Dysregulation of Rho GTPases has been studied in relation to cancer progression for a number of years [3], but accumulating evidence supports a role in traumatic brain injury and neurodegenerative diseases as well [4,5,6,7].”

    From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [4]

  • Emerging evidence points toward a role of aberrant RhoA signaling in neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis.

    “Indeed, emerging evidence points toward a role of aberrant RhoA signaling in neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis.”

    From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [4]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
DeGeer, J., & Lamarche-Vane, N.
Affiliations
McGill University (CA)
Venue
Experimental Cell Research
Publisher
Elsevier BV
Published
2013-09
Volume
319
Issue
15
Pages
2384-2394
ISSN
0014-4827 (ISSN-L)
OpenAlex
W1976841911
Cited by
46
References
119
Citations by year
2026: 4 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 5 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 7 · 2014: 3
FWCI
0.41
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental Cell Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research (MOP-14701)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Rho GTPases, neurodegeneration, intracellular signaling, effector proteins, therapeutic target, neurodegenerative diseases
MeSH terms
Animals, Gene Expression Regulation, Humans, Isoenzymes, Nerve Regeneration, Signal Transduction, Neurites, Neurodegenerative Diseases, Optic Nerve Injuries, rho GTP-Binding Proteins, Mice, Neurogenesis, Peripheral Nerve Injuries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review